<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001733278</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0002104204</issuerCik>
      <issuerName>Alamar Biosciences, Inc.</issuerName>
      <secFileNumber>001-43235</secFileNumber>
      <issuerAddress>
        <com:street1>47071 BAYSIDE PARKWAY</com:street1>
        <com:city>FREMONT</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94538</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>510-626-9888</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Qiming Venture Partners VI, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common stock, par value $0.0001 per share</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>J.P. Morgan Securities LLC</name>
        <address>
          <com:street1>270 Park Avenue</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10117</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>1558858</noOfUnitsSold>
      <aggregateMarketValue>36664000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>69392766</noOfUnitsOutstanding>
      <approxSaleDate>10/14/2026</approxSaleDate>
      <securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common stock</securitiesClassTitle>
      <acquiredDate>05/27/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Private investment in Series A-3 preferred shares, automatically converted into common stock upon IPO</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>2648607</amountOfSecuritiesAcquired>
      <paymentDate>05/26/2020</paymentDate>
      <natureOfPayment>Check</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common stock</securitiesClassTitle>
      <acquiredDate>04/30/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Private investment in Series A-4 preferred shares, automatically converted into common stock upon IPO</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>2373437</amountOfSecuritiesAcquired>
      <paymentDate>04/30/2021</paymentDate>
      <natureOfPayment>Check</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common stock</securitiesClassTitle>
      <acquiredDate>08/20/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Private investment in Series B preferred, automatically converted into common stock upon IPO</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1859366</amountOfSecuritiesAcquired>
      <paymentDate>08/18/2021</paymentDate>
      <natureOfPayment>Check</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>10/14/2026</noticeDate>
      <signature>/s/ Ho Man Lam</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
